Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantum Consciousness: A Molecular Perspective Involving Glycoprotein-Tunnelling Hypothesis (GPTH).

Current medicinal chemistry·2026
Same author

A Unified Model of Consciousness: Glycoprotein Patterns in Memory Processes and Quantum Entanglement.

Current medicinal chemistry·2025
Same author

Biochemical and <i>In Silico</i> Studies on Triazole Derivatives as Tyrosinase Inhibitors: Potential Treatment of Hyperpigmentation Related Skin Disorders.

Medicinal chemistry (Shariqah (United Arab Emirates))·2024
Same author

Diclofenac prodrugs nanoparticles: An alternative and efficient treatment for rheumatoid arthritis?

International journal of pharmaceutics·2023
Same author

Protein Folding and Molecular Basis of Memory: Molecular Vibrations and Quantum Entanglement as Basis of Consciousness.

Current medicinal chemistry·2023
Same author

Development and Validation of Embedded Device for Electrocardiogram Arrhythmia Empowered with Transfer Learning.

Computational intelligence and neuroscience·2022
Same journal

Steroidal alkaloids as multi-target therapeutics for the treatment of endometriosis.

Steroids·2026
Same journal

Emerging trends for therapeutic valuation of Cyclopamine: Structural features, mechanism of action, and formulation strategies.

Steroids·2026
Same journal

The antiproliferative and antimigratory properties of the 3-biotin-B-norcholesteryl benzimidazole derivative in MCF-7 cells are mediated through G1 phase arrest and apoptosis.

Steroids·2026
Same journal

Development and validation of an LC-MS method for quantification of sex steroid hormones in skeletal muscle.

Steroids·2026
Same journal

Circulating 4β-hydroxycholesterol as a biomarker of CYP3A4 activity: beyond drug development.

Steroids·2026
Same journal

Impact of glycosylation position on flavonoid isomers' inhibition of breast cancer-associated enzyme CYP1B1.

Steroids·2026
See all related articles

Related Experiment Video

Updated: May 28, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Pregnenolone derivatives as potential anticancer agents.

M Iqbal Choudhary1, M Shahab Alam, Atta-Ur-Rahman

  • 1H.E.J. Research Institute of Chemistry, University of Karachi, Karachi 75270, Pakistan.

Steroids
|October 4, 2011
PubMed
Summary
This summary is machine-generated.

New anticancer compounds derived from pregnenolone show significant cytotoxicity. Furanyl-containing enone 8 and pyrazoline 48 exhibit potent activity against liver and breast cancer cell lines, respectively.

More Related Videos

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

Related Experiment Videos

Last Updated: May 28, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

Area of Science:

  • Medicinal Chemistry
  • Organic Synthesis
  • Cancer Research

Background:

  • Pregnenolone serves as a foundational steroid for developing novel therapeutic agents.
  • Modification of the pregnenolone steroid core can yield compounds with diverse biological activities.
  • Identifying new anticancer drugs is crucial for combating various forms of cancer.

Purpose of the Study:

  • To synthesize and evaluate novel pregnenolone derivatives as potential anticancer agents.
  • To investigate the structure-activity relationships of modified pregnenolone compounds.
  • To identify lead compounds with significant cytotoxicity against cancer cell lines.

Main Methods:

  • Synthesis of pregnenolone derivatives including benzylidenes, pyrazolines, pyrazoles, hydrazones, and oximes.
  • Cytotoxicity assays using HepG2 (liver) and MDA-MB-230 (breast) cancer cell lines.
  • Structural elucidation of synthesized compounds, including X-ray diffraction for compound 107.

Main Results:

  • Compounds incorporating furanyl and pyridyl rings demonstrated increased cytotoxicity.
  • Heterocyclic enone 8 (IC50=0.74 μM/mL against HepG2) and derivative 17 showed significant activity.
  • Furanyl-bearing pyrazolines (e.g., 40, 42-44, 48, 49) exhibited notable cytotoxic effects.
  • Oximes, hydrazones, and pyrazoles showed no significant anticancer activity.
  • Compound 8 and its pyrazoline derivative 48 were identified as the most potent anticancer agents.

Conclusions:

  • Pregnenolone derivatives with furanyl and pyridyl moieties possess significant anticancer potential.
  • Heterocyclic enone 8 and pyrazoline 48 are promising lead compounds for further anticancer drug development.
  • Strategic modification of the pregnenolone skeleton is an effective approach for discovering novel cytotoxic agents.